Methyllycaconitine citrate salt
SIGMA/M168 - from Delphinium brownii seeds, ≥96% (HPLC)
Synonym: MLA; [1α,4(S),6β,14α,16β]-20-Ethyl-1,6,14,16-tetramethoxy-4-[[[2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl]oxy]methyl]aconitane-7,8-diol citrate salt
CAS Number: 112825-05-5
Empirical Formula (Hill Notation): C37H50N2O10 · xC6H8O7
Molecular Weight: 682.80 (salt-free basis)
MDL Number: MFCD00153837
Linear Formula: C37H50N2O10 · xC6H8O7
Product Type: Chemical
| assay | ≥96% (HPLC) |
| biological source | Delphinium brownii seeds |
| color | white |
| InChI | 1S/C37H50N2O10.C6H8O7/c1- |
| InChI key | INBLZNJHDLEWPS-DDIMIZGISA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(OC[C@]12[C@@]([C@]3([ |
| solubility | H2O: 42 mg/mL |
| storage temp. | −20°C |
| Application: | Methyllycaconitine citrate salt has been used as an α7 nicotinic acetylcholine receptor (α7 nAChR) antagonist: • to study its effects on inflammatory response in rats post nicotine treatment • to block the activity of galantamine • to study its effects on the hepatic branch of the vagus nerve (hVNS) in rats |
| Biochem/physiol Actions: | Methyllycaconitine (MLA) is an α7 nicotinic acetylcholine receptor (α7 nAChR) antagonist. It is a norditerpenoid alkaloid synthesized by several species of Delphinium. MLA binds to the binding site of neuronal α-bungarotoxin. Low doses of MLA are associated with improvement of cognition in animals. |
| Features and Benefits: | This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥96% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

